Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 22, 1999
[Antithrombotics and interventional cardiology]J P Collet, G Montalescot
Annales De Cardiologie Et D'Angeiologie|August 28, 2007
[Management coronary syndrome in the acute phase]J-P Collet, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 26, 2005
[Does diabetes affect the choice of pharmaceutical treatment in coronary artery disease?]J P Collet, G Montalescot
Hamostaseologie|November 3, 2009
P2Y12 inhibitors: thienopyridines and direct oral inhibitorsJ-P Collet, G Montalescot
American Heart Journal|December 1, 1988
Warfarin-related hemorrhage after valve replacementG Montalescot, D Thomas, Y Grosgogeat
Annales De Cardiologie Et D'Angeiologie|October 1, 1995
[What dose of aspirin should be prescribed in patients with coronary disease?]G Montalescot, G Drobinski, D Thomas
International Journal of Cardiology|May 1, 1991
Intra-myocardial haemorrhage following recanalisation of a venous coronary arterial bypass by balloon angioplastyG Drobinski, G Montalescot, M Nivet
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Non-ST acute coronary syndromes]J Ph Collet, R Choussat, G Montalescot
International Journal of Cardiology|January 1, 1984
Serious sinus node dysfunction caused by therapeutic doses of lithiumG Montalescot, Y Levy, P Y Hatt
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Review and future perspectives on low-molecular-weight heparin]J P Collet, R Choussat, G Montalescot
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 22, 1999
[Antithrombotics and interventional cardiology]J P Collet, G Montalescot
Annales De Cardiologie Et D'Angeiologie|August 28, 2007
[Management coronary syndrome in the acute phase]J-P Collet, G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 26, 2005
[Does diabetes affect the choice of pharmaceutical treatment in coronary artery disease?]J P Collet, G Montalescot
Hamostaseologie|November 3, 2009
P2Y12 inhibitors: thienopyridines and direct oral inhibitorsJ-P Collet, G Montalescot
American Heart Journal|December 1, 1988
Warfarin-related hemorrhage after valve replacementG Montalescot, D Thomas, Y Grosgogeat
Annales De Cardiologie Et D'Angeiologie|October 1, 1995
[What dose of aspirin should be prescribed in patients with coronary disease?]G Montalescot, G Drobinski, D Thomas
International Journal of Cardiology|May 1, 1991
Intra-myocardial haemorrhage following recanalisation of a venous coronary arterial bypass by balloon angioplastyG Drobinski, G Montalescot, M Nivet
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Non-ST acute coronary syndromes]J Ph Collet, R Choussat, G Montalescot
International Journal of Cardiology|January 1, 1984
Serious sinus node dysfunction caused by therapeutic doses of lithiumG Montalescot, Y Levy, P Y Hatt
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Review and future perspectives on low-molecular-weight heparin]J P Collet, R Choussat, G Montalescot
Pageof 15